Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Micro and Nano Mechanical Testing of Materials and Devices by

bigCover of the book The Risks of Knowing by

bigCover of the book ATP and the Heart by

bigCover of the book Bacterial Infections of Humans by

bigCover of the book Educating Professionals for Network-Centric Organisations by

bigCover of the book Educational Media and Technology Yearbook by

bigCover of the book An Odyssey Through the Brain, Behavior and the Mind by

bigCover of the book Pathophysiology of Heart Failure by

bigCover of the book The Biology of Alcoholism by

bigCover of the book Antiphospholipid Syndrome by

bigCover of the book Efficacy, Agency, and Self-Esteem by

bigCover of the book Fourier Transform Infrared Spectroscopy in Food Microbiology by

bigCover of the book Electrostatic and Stereoelectronic Effects in Carbohydrate Chemistry by

bigCover of the book Deviant Behavior by

bigCover of the book Analog Filters using MATLAB by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy